What is YPrime?
Founded in 2006 and headquartered in Malverne, Pennsylvania, YPrime specializes in software solutions and consulting services designed to optimize clinical trial data collection. The company provides a comprehensive suite of tools that enable biopharmaceutical firms and contract research organizations to manage information with greater precision and efficiency. By streamlining the data lifecycle, YPrime addresses the critical need for accuracy and compliance in high-stakes clinical environments, positioning itself as an essential service provider in the global health-tech ecosystem.
How much funding has YPrime raised?
YPrime has raised a total of $18.6M across 6 funding rounds:
Private Equity
$5M
Private Equity
$2.5M
Private Equity
$2M
Debt
$5M
Private Equity
$2.1M
Debt
$2M
Private Equity (2013): $5M, investors not publicly disclosed
Private Equity (2014): $2.5M, investors not publicly disclosed
Private Equity (2016): $2M, investors not publicly disclosed
Debt (2016): $5M featuring Square 1 Bank
Private Equity (2017): $2.1M, investors not publicly disclosed
Debt (2020): $2M with participation from PPP
Key Investors in YPrime
Square 1 Bank
Banc of California is a premier, relationship-focused, full-service business bank that provides a wide range of financial solutions aimed at maximizing operational efficiency for businesses at every stage of growth.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for YPrime?
With the recent infusion of $2M, YPrime is well-positioned to accelerate its product development roadmap and expand its footprint in the clinical trial management market. The strategic allocation of these funds will likely focus on enhancing the interoperability of its software platforms and deepening its consulting capabilities to meet the evolving regulatory demands of the biopharmaceutical sector. As the company enters this next phase of maturity, stakeholders can expect a continued emphasis on technological innovation and operational excellence, ensuring that YPrime remains a preferred partner for complex, multi-site clinical trials globally.
See full YPrime company page
